16306398|t|Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.
16306398|a|Neurofibrillary tangles (NFTs), neuropil threads, and neuritic elements of senile plaques predominantly comprise hyperphosphorylated tau protein and represent pathological characteristics of Alzheimer's disease (AD). These lesions occur before the presentation of clinical symptoms and correlate with the severity of dementia. In vivo detection of these lesions would thus prove useful for preclinical diagnosis of AD and for tracking disease progression. The present study introduces three novel compounds, 4-[2-(2-benzoimidazolyl)ethenyl]-N,N-diethylbenzenamine (BF-126), 2-[(4-methylamino)phenyl]quinoline (BF-158), and 2-(4-aminophenyl)quinoline (BF-170), as candidate probes for in vivo imaging of tau pathology in the AD brain. When solutions of these compounds are injected intravenously into normal mice, these agents exhibit excellent brain uptake and rapid clearance from normal brain tissue. These compounds display relatively lower binding affinity to beta-amyloid fibrils and higher binding affinity to tau fibrils, compared with previously reported probe BF-168. In neuropathological examination using AD brain sections, BF-126, BF-158, and BF-170 clearly visualize NFTs, neuropil threads, and paired helical filament-type neuritis. Autoradiography using 11C-labeled BF-158 further demonstrated labeling of NFTs in AD brain sections. These findings suggest the potential usefulness of quinoline and benzimidazole derivatives for in vivo imaging of tau pathology in AD.
16306398	0	9	Quinoline	Chemical	MESH:C037219
16306398	14	27	benzimidazole	Chemical	MESH:C031000
16306398	98	117	Alzheimer's disease	Disease	MESH:D000544
16306398	119	142	Neurofibrillary tangles	Disease	MESH:D055956
16306398	144	148	NFTs	Disease	MESH:D055956
16306398	310	329	Alzheimer's disease	Disease	MESH:D000544
16306398	331	333	AD	Disease	MESH:D000544
16306398	436	444	dementia	Disease	MESH:D003704
16306398	534	536	AD	Disease	MESH:D000544
16306398	627	682	4-[2-(2-benzoimidazolyl)ethenyl]-N,N-diethylbenzenamine	Chemical	MESH:C508375
16306398	684	690	BF-126	Chemical	MESH:C508375
16306398	693	727	2-[(4-methylamino)phenyl]quinoline	Chemical	MESH:C508376
16306398	729	735	BF-158	Chemical	MESH:C508376
16306398	742	768	2-(4-aminophenyl)quinoline	Chemical	MESH:C508377
16306398	770	776	BF-170	Chemical	MESH:C508377
16306398	843	845	AD	Disease	MESH:D000544
16306398	926	930	mice	Species	10090
16306398	1083	1095	beta-amyloid	Disease	MESH:C000718787
16306398	1188	1194	BF-168	Chemical	MESH:C485711
16306398	1235	1237	AD	Disease	MESH:D000544
16306398	1254	1260	BF-126	Chemical	MESH:C508375
16306398	1262	1268	BF-158	Chemical	MESH:C508376
16306398	1274	1280	BF-170	Chemical	MESH:C508377
16306398	1299	1303	NFTs	Disease	MESH:D055956
16306398	1356	1364	neuritis	Disease	MESH:D009443
16306398	1388	1391	11C	Chemical	MESH:C000615233
16306398	1400	1406	BF-158	Chemical	MESH:C508376
16306398	1440	1444	NFTs	Disease	MESH:D055956
16306398	1448	1450	AD	Disease	MESH:D000544
16306398	1518	1527	quinoline	Chemical	MESH:C037219
16306398	1532	1545	benzimidazole	Chemical	MESH:C031000
16306398	1598	1600	AD	Disease	MESH:D000544
16306398	Negative_Correlation	MESH:C508376	MESH:D009443
16306398	Association	MESH:C508376	MESH:D000544
16306398	Association	MESH:C508375	MESH:D055956
16306398	Association	MESH:C037219	MESH:D000544
16306398	Association	MESH:C000615233	MESH:D055956
16306398	Association	MESH:C508375	MESH:D009443
16306398	Positive_Correlation	MESH:C508376	MESH:D055956
16306398	Association	MESH:C508377	MESH:D055956
16306398	Association	MESH:C031000	MESH:D000544
16306398	Association	MESH:C508377	MESH:D000544
16306398	Association	MESH:C508377	MESH:D009443
16306398	Association	MESH:C000615233	MESH:C508376

